Ralimetinib dimesylate, CAS [[862507-23-1]]

Produktübersicht

• Artikelname: Ralimetinib dimesylate, CAS [[862507-23-1]]
• Artikelnummer: MCE-HY-13241
• Hersteller Artikelnummer: HY-13241
• Alternativnummer: MCE-HY-13241-100MG,MCE-HY-13241-10MMX1ML,MCE-HY-13241-50MG,MCE-HY-13241-10MG,MCE-HY-13241-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: LY2228820 dimesylate

Produktbeschreibung

Ralimetinib dimesylate (LY2228820 dimesylate) is a selective, ATP-competitive inhibitor of p38 MAPK alpha/beta with IC50s of 5.3 and 3.2 nM, respectively. Ralimetinib (LY2228820) selectively inhibits phosphorylation of MK2 (Thr334), with no effect on phosphorylation of p38a MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc.

Produkteigenschaften

• Molekulargewicht: 612.74
• Reinheit: 99.94
• CAS Nummer: [862507-23-1]
• Formel: C26H37FN6O6S2
• Target-Kategorie: Apoptosis,Autophagy,p38 MAPK

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound